685902-47-0Relevant articles and documents
Hypoxia-activated prodrugs: Substituent effects on the properties of nitro seco-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (nitroCBI) prodrugs of DNA minor groove alkylating agents
Tercel, Moana,Atwell, Graham J.,Yang, Shangjin,Stevenson, Ralph J.,Botting, K. Jane,Boyd, Maruta,Smith, Eileen,Anderson, Robert F.,Denny, William A.,Wilson, William R.,Pruijn, Frederik B.
scheme or table, p. 7258 - 7272 (2010/07/13)
Nitrochloromethylbenzindolines (nitroCBIs) are a new class of hypoxia-activated prodrugs for antitumor therapy. The recently reported prototypes undergo hypoxia-selective metabolism to form potent DNA minor groove alkylating agents and are selectively tox
Design and Syntheses of 1,6-Naphthalene Derivatives as Selective HCMV Protease Inhibitors
Gopalsamy, Ariamala,Lim, Kitae,Ellingboe, John W.,Mitsner, Boris,Nikitenko, Antonia,Upeslacis, Janis,Mansour, Tarek S.,Olson, Matthew W.,Bebernitz, Geraldine A.,Grinberg, Diane,Feld, Boris,Moy, Franklin J.,O'Connell, John
, p. 1893 - 1899 (2007/10/03)
Through high throughput screening of various libraries, substituted styryl naphthalene 6 was identified as an HCMV protease inhibitor. Optimization of various regions of the lead molecule using parallel synthesis resulted in 1,6-substituted naphthalenes 1